sellWeak cluster of 8
Hannay Michael Charles Ferguson sold $30k of BCYC
CHIEF PROD & SUPPLY CHAIN OFF at BICYCLE THERAPEUTICS PLC. 2,118 shares at an average of $14.16, traded Jan 2, 2025, filed Jan 6, 2025.
Warning score
35Value
$30k
2,118 shares
Holdings after
55,280
-4% from before
From 52-week low
+4%
low $13.81, close $14.36
From 52-week high
-48%
high $27.51, as of Jan 2, 2025
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price, last year
Rows in this filing
Every transaction in Form 4 0001415889-25-000922, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 2, 2025 | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 57,398 | Jan 6, 2025 |
| Jan 2, 2025 | SOpen-market sale Ordinary Shares | -1,879 | $14.09 | $26k | 55,519 | Jan 6, 2025 |
| Jan 3, 2025 | SOpen-market sale Ordinary Shares | -239 | $14.75 | $3,525 | 55,280 | Jan 6, 2025 |
| Jan 2, 2025 | AGrant or award Employee Stock Option (right to buy)derivative | +87,000 | $0.00 | $0 | 87,000 | Jan 6, 2025 |
Related signals
Other insiders at BICYCLE THERAPEUTICS PLC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 38Weak | sell 8 | BCYC BICYCLE THERAPEUTICS PLC | Arroyo Santiago CHIEF DEVELOPMENT OFFICER | $70k | 4,943 | |
| 51Moderate | sell 8 | BCYC BICYCLE THERAPEUTICS PLC | Lee Kevin CHIEF EXECUTIVE OFFICER | $173k | 12,130 | |
| 37Weak | sell 8 | BCYC BICYCLE THERAPEUTICS PLC | Skynner Michael CHIEF TECHNOLOGY OFFICER | $60k | 4,223 | |
| 44Moderate | sell 8 | BCYC BICYCLE THERAPEUTICS PLC | Milnes Alistair CHIEF OPERATING OFFICER | $78k | 5,514 | |
| 37Weak | sell 8 | BCYC BICYCLE THERAPEUTICS PLC | Crockett Nigel CHIEF BUSINESS OFFICER | $50k | 3,519 | |
| 37Weak | sell 8 | BCYC BICYCLE THERAPEUTICS PLC | Young Alethia Chief Financial Officer | $20k | 1,395 | |
| 23Weak | sell 810b5-1 | BCYC BICYCLE THERAPEUTICS PLC | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | $67k | 4,595 | |
| 50Moderate | buy | BCYC BICYCLE THERAPEUTICS PLC | BAKER BROS. ADVISORS LP director, owner | $21M | 1,485,397 | |
| 1Weak | sell10b5-1 | BCYC BICYCLE THERAPEUTICS PLC | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | $157k | 6,256 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.